IGI Laboratories Company Profile (NYSE:IG)

About IGI Laboratories

IGI Laboratories logoIGI Laboratories, Inc. is a specialty generic pharmaceutical company. Under its IGI label, the Company sells generic topical pharmaceutical products that are bioequivalent to their brand name counterparts. The Company provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. The Company has two platforms for growth: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. The Company also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics to the prescription treatment of conditions like dermatitis, psoriasis and eczema.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: IG
  • CUSIP:
Key Metrics:
  • Previous Close: $7.68
  • 50 Day Moving Average: $7.71
  • 200 Day Moving Average: $7.24
  • 52-Week Range: $4.75 - $12.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 64.00
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for IGI Laboratories (NYSE:IG) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: N/A

Analysts' Ratings History for IGI Laboratories (NYSE:IG)
Show:
DateFirmActionRatingPrice TargetDetails
10/23/2015Roth CapitalReiterated RatingBuyView Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
7/20/2015Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details
4/29/2015Avondale PartnersDowngradeOutperform -> Market PerformView Rating Details
4/7/2015Deutsche Bank AGInitiated CoverageBuy$10.00View Rating Details
3/23/2015Craig HallumReiterated RatingBuy$14.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for IGI Laboratories (NYSE:IG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/21/2015        
10/22/2015Q315($0.05)($0.02)$9.36 million$11.60 millionViewListenView Earnings Details
7/23/2015Q2($0.08)($0.04)$7.63 million$8.90 millionViewListenView Earnings Details
3/2/2015Q414$0.06$0.09$11.88 million$13.70 millionViewN/AView Earnings Details
7/24/2014($0.01)ViewN/AView Earnings Details
2/27/2014Q4$0.01($0.01)ViewListenView Earnings Details
11/13/2012Q312($0.04)$2.11 million$1.98 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IGI Laboratories (NYSE:IG)
Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $0.12 EPS

Dividends

Dividend History for IGI Laboratories (NYSE:IG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for IGI Laboratories (NYSE:IG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2015Jason Grenfell-GardnerCEOSell84,048$7.94$667,341.12View SEC Filing  
4/30/2015James C GaleDirectorBuy30,000$5.04$151,200.00View SEC Filing  
3/5/2015Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$9.95$19,900,000.00View SEC Filing  
9/2/2014Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$6.45$12,900,000.00View SEC Filing  
8/27/2014Sciences Opportunities Fu LifeMajor ShareholderSell3,000,000$6.20$18,600,000.00View SEC Filing  
8/22/2014James C GaleDirectorBuy5,000$5.90$29,500.00View SEC Filing  
8/4/2014Jason Grenfell-GardnerCEOSell66,828$5.85$390,943.80View SEC Filing  
6/9/2014Joyce EronyDirectorSell17,500$5.48$95,900.00View SEC Filing  
8/6/2013Michael B HemricDirectorBuy50,000$1.48$74,000.00View SEC Filing  
5/24/2013Jason Grenfell-GardnerCEOBuy3,500$1.55$5,425.00View SEC Filing  
3/13/2013James C GaleDirectorBuy10,000$1.33$13,300.00View SEC Filing  
3/12/2013Michael B HemricDirectorBuy20,637$1.19$24,558.03View SEC Filing  
8/14/2012Jason Grenfell-GardnerCEOBuy10,000$1.15$11,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for IGI Laboratories (NYSE:IG)
DateHeadline
News IconImprimis Pharmaceuticals Expands its Leadership Team in Operations, Quality, Manufacturing, and Client Relations (NYSE:IG)
eyewiretoday.com - August 15 at 5:52 PM
ftsenews.co.uk logoNew Broker Ratings For IGI Laboratories, Inc. (IG) - FTSE News.co.uk - FTSE News (NYSE:IG)
www.ftsenews.co.uk - August 3 at 5:55 PM
ftsenews.co.uk logoIGI Laboratories, Inc. (IG) Updated Price Targets - FTSE News (NYSE:IG)
www.ftsenews.co.uk - July 12 at 5:52 PM
News IconTeligent Receives FDA Approval For Two Topical Prescription Products (NASDAQ:TLGT) - Consumer Eagle (NYSE:IG)
www.consumereagle.com - July 9 at 8:59 AM
News IconTeligent Inc Stock Price Increases Today - Engelwood Daily (NYSE:IG)
www.engelwooddaily.com - July 7 at 5:41 PM
News IconTeligent Inc Stock Price Increases Today - Engelwood Daily (NYSE:IG)
www.engelwooddaily.com - July 7 at 5:41 PM
News IconA Reversal for Teligent Inc Is Not Near. The Stock Rises Again - Engelwood Daily (NYSE:IG)
www.engelwooddaily.com - July 7 at 8:28 AM
istreetwire.com logoStocks Buzz: Agilent Technologies (A), Waddell & Reed (WDR), Parker Hannifin (NYSE:PH) - iStreetWire (NYSE:IG)
istreetwire.com - July 5 at 5:28 PM
News IconTeligent Incorporated (NASDAQ:TLGT) Shorted Shares Decreased By 0.1% - Engelwood Daily (NYSE:IG)
www.engelwooddaily.com - July 2 at 5:27 PM
tradecalls.org logoRaymond James Initiates Coverage on Teligent Inc to Strong Buy - Trade Calls (NYSE:IG)
www.tradecalls.org - June 30 at 5:51 PM
News IconBuena pharmaceutical firm tripling plant, doubling jobs - Press of Atlantic City (NYSE:IG)
www.pressofatlanticcity.com - June 27 at 5:33 PM
breakingfinancenews.com logoTeligent (NASDAQ:TLGT) stock price target held steady to $0 as covered today by Raymond James (NYSE:IG)
breakingfinancenews.com - June 25 at 5:17 PM
fiscalstandard.com logoRecently Issued Stock Ratings For IGI Laboratories, Inc. (IG) - Fiscal Standard (NYSE:IG)
www.fiscalstandard.com - June 14 at 5:26 PM
ftsenews.co.uk logoNew Broker Ratings For IGI Laboratories, Inc. (IG) - FTSE News (NYSE:IG)
www.ftsenews.co.uk - June 3 at 8:15 AM
News IconIGI Laboratories, Inc. (IG) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News (NYSE:IG)
www.sharetrading.news - June 2 at 8:21 AM
News IconTeligent Incorporated (NASDAQ:TLGT) Sellers Covered 0.58% of Their Shorts - HNN (NYSE:IG)
hintsnewsnetwork.com - May 30 at 11:51 PM
News IconIGI Laboratories, Inc. (IG) Updated Broker Price Targets - Share Trading News (NYSE:IG)
www.sharetrading.news - May 6 at 7:45 AM
News IconIGI Laboratories, Inc. (IG) Updated Analyst Coverage - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - April 22 at 8:25 AM
News IconIGI Laboratories, Inc. (IG) - Broker Update - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - April 20 at 9:00 AM
News IconTeligent Inc Just Recorded A Sigfniciant Increase - Stock Caller (NYSE:IG)
www.stockcaller.com - April 17 at 7:15 AM
News IconAnalyst Coverage: IGI Laboratories, Inc. (IG) - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - April 13 at 1:42 PM
News IconIGI Laboratories, Inc. (IG) Analyst Review - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - April 9 at 10:48 AM
News IconTeligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 2.54% After Short Covering - RiversideGazette.com (NYSE:IG)
www.riversidegazette.com - April 5 at 12:59 PM
News IconBroker Changes For IGI Laboratories, Inc. (IG) - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - April 4 at 2:58 PM
News IconIGI Laboratories, Inc. (IG) Broker Price Targets For The Coming Week - Share Trading News (NYSE:IG)
www.sharetrading.news - April 3 at 1:10 PM
News IconDiamond Detectives - Rapaport (NYSE:IG)
www.diamonds.net - April 2 at 11:50 AM
News IconLatest Price Targets For IGI Laboratories, Inc. (IG) - Share Trading News (NYSE:IG)
www.sharetrading.news - April 1 at 1:26 PM
prnewswire.com logoTeligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of Directors - PR Newswire (press release) (NYSE:IG)
www.prnewswire.com - March 31 at 1:54 PM
News IconIGI LABORATORIES INC (NYSE:IG) rating of Reiterated Rating confirmed by Roth Capital - Hints News Network (NYSE:IG)
hintsnewsnetwork.com - March 30 at 12:52 PM
clintongazette.com logoTeligent Incorporated (NASDAQ:TLGT) Short Interest Decreased By 6.19% - Clinton Financial (NYSE:IG)
www.clintongazette.com - March 25 at 1:43 PM
News IconIGI Laboratories, Inc. (IG) Updated Price Targets - Share Trading News (NYSE:IG)
www.sharetrading.news - March 24 at 2:28 PM
prnewswire.com logoTeligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) - PR Newswire (press release) (NYSE:IG)
www.prnewswire.com - March 21 at 2:10 PM
News IconDeutsche Bank Maintains Teligent Inc to Hold with Price Target $8.00 - Street Edition (NYSE:IG)
www.streetedition.net - March 20 at 1:27 PM
News IconWith Volume of583158, Igi Laboratories Incorporated (NYSEMKT:IG) performance is mixed - The Duncan Independent (press release) (blog) (NYSE:IG)
www.duncanindependent.com - March 20 at 1:27 PM
News IconIgi Laboratories Incorporated – Will NYSEMKT:IG be able to hit earnings expectations? - The Duncan Independent (press release) (blog) (NYSE:IG)
www.duncanindependent.com - March 17 at 12:30 PM
News IconUpdated Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - March 15 at 10:07 PM
News IconNew Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - March 9 at 1:34 PM
News IconCurrent Price Targets On IGI Laboratories, Inc. (IG) - Risers & Fallers (NYSE:IG)
www.risersandfallers.com - March 2 at 1:54 PM
News IconTeligent Inc on Focus After Crashing In Today's Session - Business Standard Tribune (NYSE:IG)
www.standardtrib.com - February 29 at 8:53 PM
News IconChanges To Broker Targets On IGI Laboratories, Inc. (IG) - Share Trading News (NYSE:IG)
www.sharetrading.news - February 27 at 1:22 PM
biz.yahoo.com logoIgi Laboratories, Inc. Company Profile (NYSE:IG)
biz.yahoo.com - February 22 at 7:35 PM
News IconTeligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 3.07% After Short Covering - fdanewsalert.com (NYSE:IG)
www.fdanewsalert.com - February 19 at 12:38 PM
wallstreet.org logoTeligent Shares Rise 6% on US FDA Approval For Lidocaine Ointment USP 5% (NASDAQ:TLGT) - WallStreet.org (NYSE:IG)
www.wallstreet.org - February 3 at 10:57 AM
News IconCourt Report - January 2016 #4 - JD Supra (press release) (NYSE:IG)
www.jdsupra.com - February 2 at 10:59 AM
News IconHelix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors - SYS-CON Media (press release) (NYSE:IG)
www.sys-con.com - January 31 at 10:36 AM
biz.yahoo.com logoTELIGENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NYSE:IG)
biz.yahoo.com - December 4 at 6:05 AM
insidermonkey.com logoShould You Buy Addus Homecare Corporation (ADUS)? (NYSE:IG)
www.insidermonkey.com - November 27 at 7:08 AM
finance.yahoo.com logoTELIGENT, INC. Financials (NYSE:IG)
finance.yahoo.com - October 29 at 1:04 PM
biz.yahoo.com logoIGI LABORATORIES, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand (NYSE:IG)
biz.yahoo.com - October 14 at 8:18 AM
finance.yahoo.com logoIGI Laboratories Announces Approval For Listing On The NASDAQ Global Select Market (NYSE:IG)
finance.yahoo.com - October 14 at 8:00 AM

Social

IGI Laboratories (NYSE:IG) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff